Navigation Links
Soliris(R) Demonstrates Reductions in Hemolysis and Improvements in Fatigue, Overall Quality of Life and Anemia in a Broad Population of PNH Patients
Date:12/4/2007

estimated 8,000 to 10,000 people in North America and Western Europe.(5) PNH often strikes people in the prime of their lives, with an average age of onset in the early 30's.(6) Approximately ten percent of all patients first develop symptoms at 21 years of age or younger.(3) PNH develops without warning and can occur in men and women of all races, backgrounds and ages. PNH often goes unrecognized, with delays in diagnosis often ranging from one to more than 10 years.(2) The estimated median survival for PNH patients is between 10 and 15 years from the time of diagnosis.(2,6)

PNH has been identified more commonly among patients with disorders of the bone marrow, including aplastic anemia (AA) and myelodysplastic syndrome (MDS).(7,8,9,10) In patients with thrombosis of unknown origin, PNH may be an underlying cause.(3,11) Prior to approval of Soliris, there were no therapies specifically available for the treatment of PNH. PNH treatment was limited to symptom management through periodic blood transfusions, non-specific immunosuppressive therapy and, infrequently, bone marrow transplantation -- a procedure that carries considerable mortality risk.(3,11)

About Soliris(R)

Soliris (eculizumab) was approved in March 2007 by the U.S. Food and Drug Administration (FDA) as the first treatment for PNH, a rare, debilitating and life-threatening blood disorder defined by hemolysis, or the destruction of red blood cells. In June 2007, the European Commission (EC) also approved the use of Soliris (eculizumab) for the treatment of patients with PNH. Soliris is the first therapy approved in Europe for the treatment of PNH and was the first medicinal product to receive EU approval under the EMEA Accelerated Assessment Procedure.

Important Safety Information

Soliris is generally well tolerated. The most frequent adverse events observed in clinical studies were headache, nasopharyngitis (a runny nose), back pain and nausea. Treatment with Soliris sh
'/>"/>

SOURCE Alexion Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Cytokine Demonstrates Oral Efficacy of Small-Molecule MIF Inhibitors
2. Lpath Demonstrates Strong Safety Profile of Lead Drug Candidate, Sphingomab(TM), in Non-Human Primates
3. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
4. New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia
5. Cypher(R) Sirolimus-Eluting Coronary Stent Demonstrates Sustained Clinical Benefits Compared to Bare Metal Stents in Five-Year Randomized Clinical Trial With No Differences in Long-Term Safety
6. Lpath Demonstrates Preclinical Efficacy of Lpathomab(TM) and Initiates Humanization Process
7. R7128 Demonstrates Safety and Potent Antiviral Activity in HCV-Infected Patients
8. Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial
9. New Study Demonstrates 4 Year Olds Fed Enfamil LIPIL(R) as Infants Have Brain and Eye Outcomes Similar to Breastfed Babies
10. ACTOS(R) (pioglitazone HCl) Demonstrates Reduced Risk of Ischemic Cardiovascular Disease in Patients with Type 2 Diabetes
11. Oritavancin Demonstrates Superior In Vitro Activity to Vancomycin and Metronidazole Against C. Difficile Bacteria
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... , March 26, 2015 Huntington Memorial ... Valley to perform transcatheter aortic valve replacement (TAVR), a ... is a revolutionary new way to replace an aortic ... a heart lung machine. The procedure is ... led by Azhil ( Alex) Durairaj , MD, interventional ...
(Date:3/26/2015)... , March 26, 2015 When ... by their existing PACS vendor their system would ... determined that they needed a better structured solution ... selected Avreo interWORKS due to its interface capabilities ... meaningful use standards through to the hospital,s radiology ...
(Date:3/26/2015)... Calif. , March 26, 2015  Desert Valley ... Nation five times , is the first U.S. ... in its emergency department to help clinicians prevent hospital ... Victorville, Calif. , is a community ... bariatric patients.  Using the Leaf Patient Monitor in the ...
Breaking Medicine Technology:Huntington Memorial Hospital Performs Groundbreaking Minimally Invasive Replacement of Heart Valves 2Clinch Memorial Hospital Modernizes Workflow with Avreo interWORKS 2Desert Valley Medical Center First to Use Leaf Healthcare Patient Wearable Technology in its ED as Part of Hospital-wide Deployment 2Desert Valley Medical Center First to Use Leaf Healthcare Patient Wearable Technology in its ED as Part of Hospital-wide Deployment 3
... Inc. (Nasdaq: AKRX ) will host a conference ... results followed by a Q&A session.  The company will release ... Akorn Third Quarter 2010 Conference CallDate/Time: , Tuesday, ... (888) 215-6895International Callers: , (913) 312-0860Confirmation Code: ...
... Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN ) announced ... offering of 5,500,000 shares of Common Stock, as well ... to the full exercise of the over-allotment option granted ... (before estimated offering expenses) were approximately $175.1 million.  Citi ...
Cached Medicine Technology:Regeneron Announces Exercise of Over-Allotment Option and Closing of Underwritten Offering of Common Stock 2Regeneron Announces Exercise of Over-Allotment Option and Closing of Underwritten Offering of Common Stock 3
(Date:3/26/2015)... March 26, 2015 Innovative research ... aneurysms and preventing often fatal ruptures, says The ... to raising awareness of brain aneurysms and funding ... has captured national attention with the death ... who died last Friday after suffering a ruptured ...
(Date:3/26/2015)... March 26, 2015 The ... Patients’ Access to Treatments Act (PATA) that was ... by Reps. David B. McKinley (R-WV) and Lois ... cost-sharing requirements for medications placed in a specialty ... reducing patients’ out-of-pocket expenses. , This legislation is ...
(Date:3/26/2015)... March 26, 2015 In preparation for ... Fitness Revolution, founded by Samir Becic, has issued ... own personal health and fitness, as well as their ... The list includes Sen. Ted Cruz, who has officially ... as all other politicians who have shown interest in ...
(Date:3/26/2015)... Md. (PRWEB) March 26, 2015 Los ... in a pageant. Not until last year, when she ... Eliana has pulmonary hypertension (PH) – a debilitating disease ... heart and can lead to right-heart failure. The disease ... born in 2003. Lyndsi entered the pageant to raise ...
(Date:3/26/2015)... 2015 DiabetesSisters is pleased to announce ... of $25,000 for a groundbreaking project in the field ... a partnering organization, The Society for Women’ Health Research, ... on women and diabetes. The “Women & Diabetes: 10Q ... research to improve the health and wellbeing of women ...
Breaking Medicine News(10 mins):Health News:Research and Funding Are Keys to Raising Awareness and Ultimately Preventing Fatal Brain Aneurysm Ruptures 2Health News:Research and Funding Are Keys to Raising Awareness and Ultimately Preventing Fatal Brain Aneurysm Ruptures 3Health News:Pulmonary Hypertension Association Part of Coalition Supporting the Patients’ Access to Treatments Act 2Health News:How the Candidates for the 2016 Presidential Election Rank in Health and Fitness 2Health News:How the Candidates for the 2016 Presidential Election Rank in Health and Fitness 3Health News:Albuquerque Area Mom Enters Mrs. New Mexico Pageant to Help Fight Pulmonary Hypertension 2Health News:DiabetesSisters Receives Financial Support for Landmark Report from Janssen Pharmaceuticals 2
... ban by the government, asbestos might still be illegally ... toxic mineral on a large scale, a Canadian social// ... working on mining issues in Canada for 12 years, ... with asbestos mining. ,Palu, accompanied by a ...
... Female genital mutilation (FGM), excision of clitoris is practiced ... without the use of anesthetics. A senior doctor ... that is going on for generations, sorting out the ... published on bmj.com last month probes that the procedure ...
... throughout the country to manage over six million children ... Madras ENT Rearch Foundation Charitable Trust Mohan Kameshwaran said ... concentrated in major cities, which made treatment and rehabilitation ... to the inauguration of the MERF Institute of Speech ...
... -- intrauterine insemination with controlled ovarian hyperstimulation – is only ... for some couples. ,The results of the study ... research was conducted on 253 couples with unexplained infertility who'd ... cases where no obvious abnormalities were found. ,The ...
... type-1 diabetes are more prone to develop multiple sclerosis ... reveals.// ,Both type-1 diabetes and MS are ... immune response against itself, attacking insulin-producing cells in patients ... in those suffering from MS. , Dr. ...
... to thicken everything from baby food to sexual lubricants ... and genital warts. ,Researchers found the thickener, ... cells in laboratory tests. Certain strains of HPV can ... the study conducted by researchers from the National Cancer ...
Cached Medicine News:Health News:Despite Ban, Asbestos Produce Goes Unhindered 2Health News:Common Chemical From Seaweed Could Help In The Fight Against Cervical Cancer Virus-HPV 2
... a high resolution diagnostic test for cholesterol components ... The test procedure is simple and can be ... value is clearly flagged. A color coded profile ... LDL in red and the good HDL in ...
... This control is designed to validate ... and apolipoprotein testing methods. This control is ... Series, Cobas, Dimension, Hitachi, Synchron and Vitros. ... methods and HDL precipitation methods: Dextran Sulfate ...
... control monitors spinal fluid analyte methods to ... Control is packaged in dropper-tip bottles for ... need for pipets and minimizing waste. Values ... major chemistry analyzers and nephelometers: Abbott Aeroset, ...
... Suitable for use with ... BR2 bilirubinometers (pediatric) and all ... instruments including Aeroset, AU Series, ... Vitros. These controls contain purified ...
Medicine Products: